These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2885064)

  • 1. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; Navarro JA; Benito-León J; Ortí-Pareja M; Gasalla T; Cisneros E; Arenas J
    J Neurol Sci; 1996 Sep; 141(1-2):39-44. PubMed ID: 8880690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia.
    Manyam BV; Giacobini E; Ferraro TN; Hare TA
    Arch Neurol; 1990 Nov; 47(11):1194-9. PubMed ID: 1978660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's disease - imbalance of free amino acids in the cerebrospinal fluid of patients and offspring at-risk.
    Oepen G; Cramer H; Bernasconi R; Martin P
    Arch Psychiatr Nervenkr (1970); 1982; 231(2):131-40. PubMed ID: 6461312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind clinical trial of isoniazid in Huntington disease.
    Perry TL; Wright JM; Hansen S; Thomas SM; Allan BM; Baird PA; Diewold PA
    Neurology; 1982 Apr; 32(4):354-8. PubMed ID: 6460947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of isoniazid therapy for action tremor in multiple sclerosis.
    Bozek CB; Kastrukoff LF; Wright JM; Perry TL; Larsen TA
    J Neurol; 1987 Jan; 234(1):36-9. PubMed ID: 3546605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased plasma alanine and isoleucine in Huntington's disease.
    Reilmann R; Rolf LH; Lange HW
    Acta Neurol Scand; 1995 Mar; 91(3):222-4. PubMed ID: 7793240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
    Perry TL; Wall RA; Hansen S
    Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
    Manyam BV; Tremblay RD
    Brain Res; 1984 Jul; 307(1-2):217-23. PubMed ID: 6235893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF gradients for amino acid neurotransmitters.
    Crawford PM; Lloyd KG; Chadwick DW
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1193-200. PubMed ID: 2906363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-aminoacid levels in Huntington's chorea.
    Perry TL; Diamond S; Hansen S; Stedman D
    Lancet; 1969 Apr; 1(7599):806-8. PubMed ID: 4180363
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies.
    Molina JA; Gómez P; Vargas C; Ortiz S; Pérez-Rial S; Urigüen L; Oliva JM; Villanueva C; Manzanares J
    J Neural Transm (Vienna); 2005 Apr; 112(4):557-63. PubMed ID: 15365790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF and serum metabolic profile of patients with Huntington's chorea: a study by high resolution proton NMR spectroscopy and HPLC.
    Nicoli F; Vion-Dury J; Maloteaux JM; Delwaide C; Confort-Gouny S; Sciaky M; Cozzone PJ
    Neurosci Lett; 1993 May; 154(1-2):47-51. PubMed ID: 8361646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate in pyridoxine-dependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine.
    Baumeister FA; Gsell W; Shin YS; Egger J
    Pediatrics; 1994 Sep; 94(3):318-21. PubMed ID: 7915028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated cerebrospinal fluid histidine in alcohol withdrawal.
    Hawley RJ; Schulman E; Major LF; Poplack J; Catravas GN
    Alcohol; 1988; 5(4):321-3. PubMed ID: 3228484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid and Huntington's chorea.
    Roccatagliata G; Albano C
    N Engl J Med; 1978 Feb; 298(8):457. PubMed ID: 146161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.